{
  "containers": {
    "adp": [
      {
        "providerMetadata": {
          "dateUpdated": "2024-08-06T06:04:01.128Z",
          "orgId": "af854a3a-2127-422b-91ae-364da2661108",
          "shortName": "CVE"
        },
        "references": [
          {
            "tags": [
              "x_refsource_MISC",
              "x_transferred"
            ],
            "url": "https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01"
          }
        ],
        "title": "CVE Program Container"
      }
    ],
    "cna": {
      "affected": [
        {
          "product": "Plum A+ Infusion System",
          "vendor": "Hospira",
          "versions": [
            {
              "status": "affected",
              "version": "\u003c= 13.4"
            }
          ]
        },
        {
          "product": "Plum A+3 Infusion System",
          "vendor": "Hospira",
          "versions": [
            {
              "status": "affected",
              "version": "\u003c= 13.6"
            }
          ]
        },
        {
          "product": "Symbiq Infusion System",
          "vendor": "Hospira",
          "versions": [
            {
              "status": "affected",
              "version": "\u003c= 3.13"
            }
          ]
        }
      ],
      "datePublic": "2015-06-10T00:00:00",
      "descriptions": [
        {
          "lang": "en",
          "value": "Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue."
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "cweId": "CWE-285",
              "description": "Improper authorization CWE-285",
              "lang": "en",
              "type": "CWE"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2019-03-25T16:12:01",
        "orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
        "shortName": "icscert"
      },
      "references": [
        {
          "tags": [
            "x_refsource_MISC"
          ],
          "url": "https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01"
        }
      ],
      "x_legacyV4Record": {
        "CVE_data_meta": {
          "ASSIGNER": "ics-cert@hq.dhs.gov",
          "ID": "CVE-2015-3954",
          "STATE": "PUBLIC"
        },
        "affects": {
          "vendor": {
            "vendor_data": [
              {
                "product": {
                  "product_data": [
                    {
                      "product_name": "Plum A+ Infusion System",
                      "version": {
                        "version_data": [
                          {
                            "version_value": "\u003c= 13.4"
                          }
                        ]
                      }
                    },
                    {
                      "product_name": "Plum A+3 Infusion System",
                      "version": {
                        "version_data": [
                          {
                            "version_value": "\u003c= 13.6"
                          }
                        ]
                      }
                    },
                    {
                      "product_name": "Symbiq Infusion System",
                      "version": {
                        "version_data": [
                          {
                            "version_value": "\u003c= 3.13"
                          }
                        ]
                      }
                    }
                  ]
                },
                "vendor_name": "Hospira"
              }
            ]
          }
        },
        "data_format": "MITRE",
        "data_type": "CVE",
        "data_version": "4.0",
        "description": {
          "description_data": [
            {
              "lang": "eng",
              "value": "Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue."
            }
          ]
        },
        "problemtype": {
          "problemtype_data": [
            {
              "description": [
                {
                  "lang": "eng",
                  "value": "Improper authorization CWE-285"
                }
              ]
            }
          ]
        },
        "references": {
          "reference_data": [
            {
              "name": "https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01",
              "refsource": "MISC",
              "url": "https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01"
            }
          ]
        }
      }
    }
  },
  "cveMetadata": {
    "assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
    "assignerShortName": "icscert",
    "cveId": "CVE-2015-3954",
    "datePublished": "2019-03-25T16:12:01",
    "dateReserved": "2015-05-12T00:00:00",
    "dateUpdated": "2024-08-06T06:04:01.128Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.1"
}